Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial
Titel:
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial
Auteur:
Mir, Olivier Brodowicz, Thomas Italiano, Antoine Wallet, Jennifer Blay, Jean-Yves Bertucci, François Chevreau, Christine Piperno-Neumann, Sophie Bompas, Emmanuelle Salas, Sébastien Perrin, Christophe Delcambre, Corinne Liegl-Atzwanger, Bernadette Toulmonde, Maud Dumont, Sarah Ray-Coquard, Isabelle Clisant, Stéphanie Taieb, Sophie Guillemet, Cécile Rios, Maria Collard, Olivier Bozec, Laurence Cupissol, Didier Saada-Bouzid, Esma Lemaignan, Christine Eisterer, Wolfgang Isambert, Nicolas Chaigneau, Loïc Cesne, Axel Le Penel, Nicolas